세계의 X선 시스템 시장 규모, 점유율, 동향 분석 보고서 : 모달리티별, 기술별, 모빌리티별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

X-ray Systems Market Growth & Trends:

The global x-ray systems market size is expected to reach USD 10.16 billion by 2030, registering a CAGR of 3.28% from 2025 to 2030, according to a new report by Grand View Research, Inc. Technological advancements in the healthcare sector and supportive investments by the government are driving the market. In addition, increase in the demand for early-stage diagnosis of chronic diseases and screening programs are expected to boost market growth.

Emerging innovations in the x-ray systems is expanding the market size, such as integration of Artificial Intelligence (AI) in medical imaging systems, robotic, and mobile x-ray systems have made the technology more accessible for use in limited-resource communities around the world. For instance, in March 2021, Philips healthcare announced partnership with Lunit, a leading medical AI startup, with this collaboration Lunit's INSIGHT CXR chest detection suite will be incorporated into Philips diagnostic x-ray suite, to achieve better patient outcomes, improve the experience of patients and staff, and lower the cost of care.

The rising prevalence and awareness of chronic diseases like cancer, neurological conditions, orthopedics and cardiovascular diseases, which demands the adoption of x-ray systems for diagnosis are expected to expand the market during forecast period. Furthermore, the growing adoption of Digital Radiography (DR) is expected to boost the market growth as DR systems produces, high contrast resolution images at a lower ionizing radiation.

The market's prominent competitors are taking different initiatives such as acquisition, funding, and product development in order to expand their product portfolio and enhance their manufacturing capacity. For instance, in November 2020, GE healthcare announced the first AI algorithms set in a mobile x-ray device for automated measurements, case prioritization and quality control.

X-ray Systems Market Report Highlights:

• The radiography segment dominated the market and is further expected to continue its dominance over the forecast period, as it is the initial diagnostic imaging step recommended by doctors on their way to a definitive diagnosis.
• Digital Radiography (DR) held the largest market share in 2024 and is also expected to grow at the fastest CAGR of 3.64% over the forecast period. This growth can be attributed primarily to the increasing demand for DR systems.
• The stationary X-ray systems segment dominated the market in 2024. Their dominance is attributed to their cost-effectiveness and the lower initial investment required compared to more advanced imaging technologies.
• The hospital segment dominated the market by capturing a share of about 42.65% in 2024. In outpatient settings, the X-ray system is a substantial source of revenue.
• The X-ray systems market in Asia Pacific is expected to witness the fastest CAGR during the forecast period, owing to the increased demand for better imaging devices and supportive government initiatives to improve healthcare infrastructure in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Modality
  • 1.2.2. Technology
  • 1.2.3. Mobility
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Technology outlook
  • 2.2.3. Mobility outlook
  • 2.2.4. End use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. X-ray Systems Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing trends of preventive healthcare and screening programs
    • 3.2.1.2. Increasing number of government initiatives
    • 3.2.1.3. Rapid Technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Increasing use of refurbished products
    • 3.2.2.2. High cost of digital x-ray systems
• 3.3. X-ray Systems Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. X-ray Systems Market: Modality Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global X-ray Systems Modality Market Movement Analysis
• 4.3. Global X-ray Systems Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
• 4.4. Radiography
  • 4.4.1. Radiography market estimates and forecasts 2018 - 2030 (USD Million)
• 4.5. Fluoroscopy
  • 4.5.1. Fluoroscopy market estimates and forecasts 2018 - 2030 (USD Million)
• 4.6. Mammography
  • 4.6.1. Mammography market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. X-ray Systems Market: Technology Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global X-ray Systems Technology Market Movement Analysis
• 5.3. Global X-ray Systems Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 5.4. Digital radiography
  • 5.4.1. Digital radiography market estimates and forecasts 2018 - 2030 (USD Million)
• 5.5. Computed radiography
  • 5.5.1. Computed radiography market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. X-ray Systems Market: Mobility Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global X-ray Systems Mobility Market Movement Analysis
• 6.3. Global X-ray Systems Market Size & Trend Analysis, by Mobility, 2018 to 2030 (USD Million)
• 6.4. Stationary
  • 6.4.1. Stationary market estimates and forecasts 2018 - 2030 (USD Million)
• 6.5. Mobile
  • 6.5.1. Mobile market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. X-ray Systems Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global X-ray Systems End Use Market Movement Analysis
• 7.3. Global X-ray Systems Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
• 7.5. Diagnostic Imaging Centers
  • 7.5.1. Diagnostic imaging centers market estimates and forecasts 2018 - 2030 (USD Million)
• 7.6. Other End Users
  • 7.6.1. Others end users market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. X-ray Systems Market: Regional Estimates & Trend Analysis By Modality, Technology, Mobility, End Use

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement structure
    • 8.5.1.5. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement structure
    • 8.5.2.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement structure
    • 8.5.3.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement structure
    • 8.6.1.5. UK market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement structure
    • 8.6.2.5. Germany market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement structure
    • 8.6.3.5. France market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Reimbursement structure
    • 8.6.4.5. Italy market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Reimbursement structure
    • 8.6.5.5. Spain market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. Reimbursement structure
    • 8.6.6.5. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Reimbursement structure
    • 8.6.7.5. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Competitive scenario
    • 8.6.8.3. Regulatory framework
    • 8.6.8.4. Reimbursement structure
    • 8.6.8.5. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement structure
    • 8.7.1.5. Japan market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement structure
    • 8.7.2.5. China market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement structure
    • 8.7.3.5. India market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement structure
    • 8.7.4.5. Australia market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Reimbursement structure
    • 8.7.5.5. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Competitive scenario
    • 8.7.6.3. Regulatory framework
    • 8.7.6.4. Reimbursement structure
    • 8.7.6.5. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Competitive scenario
    • 8.8.1.3. Regulatory framework
    • 8.8.1.4. Reimbursement structure
    • 8.8.1.5. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. Reimbursement structure
    • 8.8.2.5. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Competitive scenario
    • 8.9.1.3. Regulatory framework
    • 8.9.1.4. Reimbursement structure
    • 8.9.1.5. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Competitive scenario
    • 8.9.2.3. Regulatory framework
    • 8.9.2.4. Reimbursement structure
    • 8.9.2.5. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Competitive scenario
    • 8.9.3.3. Regulatory framework
    • 8.9.3.4. Reimbursement structure
    • 8.9.3.5. UAE market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Competitive scenario
    • 8.9.4.3. Regulatory framework
    • 8.9.4.4. Reimbursement structure
    • 8.9.4.5. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Key company market share analysis, 2024
• 9.4. Company Position Analysis
• 9.5. Company Categorization (Emerging Players, Innovators and Leaders
• 9.6. Company Profiles
  • 9.6.1. Koninklijke Philips N.V.
    • 9.6.1.1. Company overview
    • 9.6.1.2. Financial performance
    • 9.6.1.3. Device benchmarking
    • 9.6.1.4. Strategic initiatives
  • 9.6.2. Siemens Healthineers AG
    • 9.6.2.1. Company overview
    • 9.6.2.2. Financial performance
    • 9.6.2.3. Device benchmarking
    • 9.6.2.4. Strategic initiatives
  • 9.6.3. GE Healthcare
    • 9.6.3.1. Company overview
    • 9.6.3.2. Financial performance
    • 9.6.3.3. Device benchmarking
    • 9.6.3.4. Strategic initiatives
  • 9.6.4. Canon Medical Systems
    • 9.6.4.1. Company overview
    • 9.6.4.2. Financial performance
    • 9.6.4.3. Device benchmarking
    • 9.6.4.4. Strategic initiatives
  • 9.6.5. Shimadzu Corporation
    • 9.6.5.1. Company overview
    • 9.6.5.2. Financial performance
    • 9.6.5.3. Device benchmarking
    • 9.6.5.4. Strategic initiatives
  • 9.6.6. FUJIFILM SonoSite, Inc.
    • 9.6.6.1. Company overview
    • 9.6.6.2. Financial performance
    • 9.6.6.3. Device benchmarking
    • 9.6.6.4. Strategic initiatives
  • 9.6.7. Carestream
    • 9.6.7.1. Company overview
    • 9.6.7.2. Financial performance
    • 9.6.7.3. Device benchmarking
    • 9.6.7.4. Strategic initiatives
  • 9.6.8. Mindray Medical International Limited
    • 9.6.8.1. Company overview
    • 9.6.8.2. Financial performance
    • 9.6.8.3. Device benchmarking
    • 9.6.8.4. Strategic initiatives
  • 9.6.9. Hologic, Inc
    • 9.6.9.1. Company overview
    • 9.6.9.2. Financial performance
    • 9.6.9.3. Device benchmarking
    • 9.6.9.4. Strategic initiatives
  • 9.6.10. New Medical Imaging
    • 9.6.10.1. Company overview
    • 9.6.10.2. Financial performance
    • 9.6.10.3. Device benchmarking
    • 9.6.10.4. Strategic initiatives
  • 9.6.11. AGFA
    • 9.6.11.1. Company overview
    • 9.6.11.2. Financial performance
    • 9.6.11.3. Device benchmarking
    • 9.6.11.4. Strategic initiatives